Related Experiment Videos

General mechanisms of carcinogenesis and anticarcinogenesis

N Voiculetz¹, I Niculescu-Duvăz

¹Institute of Oncology, Bucharest, Romania.

Archives Roumaines De Pathologie Experimentales Et De Microbiologie

|April 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Development of an outpatient finger-prick glomerular filtration rate procedure suitable for epidemiological studies.

Kidney international·2006

NCI-EORTC-AACR--11th Symposium on New Drugs in Cancer Therapy: Gene therapy and new drugs. 7-10 November 2000, Amsterdam, The Netherlands.

IDrugs : the investigational drugs journal·2005

Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.

Journal of medicinal chemistry·2004

Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.

Current opinion in molecular therapeutics·2001

Thymitaq (Zarix).

Current opinion in investigational drugs (London, England : 2000)·2001

See all related articles